Insider track record
OtherNot enough buy signals with a settled T+90 horizon to measure a track record yet.
Explore the full record of transactions filed by Hewes L. Becker. Insider active across 1 company, notably Blueprint Medicines Corp. In total, 23 reports have been logged. Split: 0 buy · 10 sells. Total volume traded: €1.5m. History available since 2 June 2021. The latest transaction was filed on 5 March 2025 (Cession). Regulator: SEC (Form 4). The full history is free.
Declarations23 total
4,863 shares@ US$88.8012.2% of flowCommon StockSEC:0001415889-25-007407:0
11,000 shares0Common StockSEC:0001415889-25-006611:0
2,424 shares@ US$104.917.0% of flowCommon StockSEC:0001415889-24-015734:0
10,573 shares@ US$66.2419.3% of flowCommon StockSEC:0001415889-24-015315:0
3,097 shares@ US$90.697.7% of flowCommon StockSEC:0001415889-24-007562:0
12,500 shares0Common StockSEC:0001415889-24-007015:0
1,404 shares@ US$52.052.0% of flowCommon StockSEC:0001415889-23-009402:0
1,466 shares@ US$45.721.9% of flowCommon StockSEC:0001415889-23-004563:0
12,500 shares0Common StockSEC:0001415889-23-004265:0
1,220 shares@ US$59.764.1% of flowCommon StockSEC:0001415889-22-006307:0
2,219 shares@ US$60.007.3% of flowCommon StockSEC:0001415889-22-003186:0
1,047 shares@ US$56.193.2% of flowCommon StockSEC:0001415889-22-002734:0
8,750 shares0Common StockSEC:0001415889-22-002439:0
729 shares@ US$66.241.3% of flowCommon StockSEC:0001179110-21-011105
729 shares@ US$66.242.6% of flowCommon StockSEC:0001179110-21-011105:0
729 shares@ US$66.242.5% of flowCommon StockSEC:0001179110-21-010209:0
729 shares@ US$66.241.3% of flowCommon StockSEC:0001179110-21-010209
729 shares@ US$66.242.5% of flowCommon StockSEC:0001179110-21-009515:0
729 shares@ US$66.241.2% of flowCommon StockSEC:0001179110-21-009515
1,292 shares@ US$89.035.7% of flowCommon StockSEC:0001179110-21-008826:0
8,750 shares@ US$66.2429.4% of flowCommon StockSEC:0001179110-21-008827:0
8,750 shares@ US$66.2414.7% of flowCommon StockSEC:0001179110-21-008827
1,292 shares@ US$89.032.8% of flowCommon StockSEC:0001179110-21-008826
About Hewes L. Becker
Hewes L. Becker is a director at Blueprint Medicines Corp.